LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/FDA Clears SI BONE’s Latest SI Fusion Innovation
Legal & Regulatory and Reimbursement

FDA Clears SI BONE’s Latest SI Fusion Innovation

September 26, 2023 1 min read Premium comments

Advertisement

FDA Clears SI BONE’s Latest SI Fusion Innovation
iFuse Bedrock Granite® Implant System / Courtesy of SI-BONE, Inc.
#siboneSecondary#ifuseimplant

The FDA has cleared six additional posterior spinal fixation rods for use as pelvic implant devices.

The agency’s 510(k) clearances covered six variations on the iFuse Bedrock Granite® Implant System. The system is intended for sacroiliac joint fusion for the following conditions:

  • Sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
  • To augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion.
  • Acute, non-acute, and non-traumatic fractures involving the sacroiliac joint.

Silicon Valley-based SI-BONE, Inc. submitted the device for 510(k) clearance. With clearance, the device now has expanded compatibility. SI-BONE recently announced that “certain CD Horizon® Solera® 5.5mm and 6.0mm posterior spinal fixation rods manufactured by Medtronic Sofamor Danek USA Inc., a division of Medtronic plc, meet SI-BONE’s criteria for compatibility.”

According to SI-BONE, the following Medtronic CD Horizon Solera rods meet iFuse Bedrock Granite implant compatibility criteria:

  • CD HORIZON SOLERA Ø5mm Lined Titanium Alloy Straight Rod, length = 500mm
  • CD HORIZON SOLERA Ø0mm Lined Titanium Alloy Straight Rod, length = 500mm
  • CD HORIZON SOLERA Ø5mm Lined CHROMALOY Straight Rod, length = 500mm
  • CD HORIZON SOLERA Ø5mm Lined CHROMALOY Plus Straight Rod, length = 600mm
  • CD HORIZON SOLERA Ø0mm Lined CHROMALOY Straight Rod, length = 500mm
  • CD HORIZON SOLERA Ø0mm Lined CHROMALOY Plus Straight Rod, length = 500mm

SI-BONE CEO Laura Francis said, “Given the strong initial reception for Granite, we are thrilled to confirm that a number of Medtronic’s Solera® rods, used by many spine surgeons, meet Granite’s compatibility criteria.”

Francis continued, “Our existing general rod compatibility clearance, along with confirmation that these Medtronic Solera rods meet the criteria for compatibility with the Granite implant will give spine surgeons additional confidence in using our leading pelvic fixation implant with the Medtronic Solera system.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy